-
Do you have any unwanted, unused, or expired prescriptions? Coloradans can drop off those drugs between 10 and 2 Saturday.The event is part of the Drug…
-
Wondering what to do with that Vicodin that's gathering dust in the medicine cabinet? The DEA is happy to take it off your hands. That method spares the environment and solves a pesky problem: giving a narcotic like that to anyone other than the person whose name is on the prescription is a felony.
-
A push to make narcotic painkillers harder to abuse means that generic versions of OxyContin won't be allowed. But drugs that are more resistant to abuse are expensive and can still be addictive.
-
The Indianapolis-based pharmaceutical company announced on Thursday that about 1,000 sales representatives will lose their jobs. The Wall Street Journal reports the company made the move to cut costs so it can better compete with generic drug makers.
-
In many parts of the South, more than one-third of seniors are taking drugs that they should avoid, an analysis of Medicare data finds. Ten percent are taking two or more potentially problematic medicines.
-
Researchers put some old elixirs and pills in the Henry Ford Museum's large collection of patent medicines to a modern test. They found a mix of potentially harmful metals like lead and mercury along with benign ingredients, including calcium and iron.
-
A study of statin use in the real world found that 17 percent of patients taking the pills reported side effects, including muscle pain, nausea, and problems with their liver or nervous system. Many of those people quit taking the pills, at least temporarily.
-
Novartis lost its bid to patent one of its cancer drugs. Indian authorities say the drug is too much like an earlier version. Novartis says the ruling may dampen drug companies' willingness to work in India. Others say the ruling will help make less expensive drugs available to the world's poor.
-
A U.S. attorney said "good corporate citizens" have an obligation curb the sale of illegal drugs. UPS, the government said, was aware some of its customers were ordering controlled substances illegally.
-
It's remarkably rare for leading research hospitals to reject new drugs because of cost.